Vimarsana
Biggest News Aggregation in the World

Page 19 - Optune Lua News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Optune Lua. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Optune Lua Today - Breaking & Trending Today

NovoCure (NASDAQ:NVCR) Earns Buy Rating from Analysts at HC Wainwright - Vimarsana News

NovoCure (NASDAQ:NVCR) Earns Buy Rating from Analysts at HC Wainwright

Equities research analysts at HC Wainwright started coverage on shares of NovoCure (NASDAQ:NVCR – Get Rating) in a research note issued to investors on Monday, The Fly reports. The brokerage set a “buy” rating on the medical equipment provider’s stock. NVCR has been the topic of several other research reports. Truist Financial upgraded shares of […]

Zai Lab Announces First Quarter 2022 Financial Results and - Vimarsana News

Zai Lab Announces First Quarter 2022 Financial Results and

Company to Host Conference Call and Webcast on May 11, 2022, at 8:00 a.m. ET...

NovoCure (NVCR) to Release Quarterly Earnings on Thursday - Vimarsana News

NovoCure (NVCR) to Release Quarterly Earnings on Thursday

NovoCure (NASDAQ:NVCR – Get Rating) is scheduled to be announcing its earnings results before the market opens on Thursday, April 28th. Analysts expect the company to announce earnings of ($0.17) per share for the quarter. Parties interested in listening to the company’s conference call can do so using this link. NovoCure (NASDAQ:NVCR – Get Rating) […]

Zacks: Analysts Anticipate NovoCure Limited (NASDAQ:NVCR) Will Announce Earnings of -$0.17 Per Share - Vimarsana News

Zacks: Analysts Anticipate NovoCure Limited (NASDAQ:NVCR) Will Announce Earnings of -$0.17 Per Share

Brokerages expect that NovoCure Limited (NASDAQ:NVCR – Get Rating) will announce earnings of ($0.17) per share for the current quarter, Zacks reports. Five analysts have made estimates for NovoCure’s earnings, with the lowest EPS estimate coming in at ($0.22) and the highest estimate coming in at ($0.11). NovoCure posted earnings of ($0.04) per share in […]

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Hold" by Brokerages - Vimarsana News

NovoCure Limited (NASDAQ:NVCR) Given Consensus Rating of "Hold" by Brokerages

NovoCure Limited (NASDAQ:NVCR – Get Rating) has earned a consensus recommendation of “Hold” from the eleven analysts that are covering the stock, Marketbeat.com reports. Two analysts have rated the stock with a sell recommendation, three have given a hold recommendation and five have issued a buy recommendation on the company. The average twelve-month price objective […]